In addition, the expression of the alternative activation marker CD163 in TAMs strongly correlates with elevated IL6, IL10, TGFβ, and polyunsaturated fatty acids (PUFAs) levels, in particular, arachidonic acid, which are signaling mediators and/or prognostic markers in ovarian cancer at different levels [41,50,51,52,53,54,55]. Here, CD163 is linked to ovarian carcinoma.